The 20 Best Medulloblastoma Doctors near San Francisco, CA

Dr. David Raleigh is a radiation oncologist who specializes in brain tumors. He cares for both adult and pediatric patients. Raleigh's research focuses on understanding the biological processes that cause brain tumors to grow. His goals are to uncover new measures of brain cancer and to identify cells for drugs to target. Raleigh earned a bachelor's degree in molecular and cell biology as well as a bachelor's degree in cognitive science from the University of California, Berkeley. He earned his doctoral degree in molecular pathogenesis – how disease develops at the molecular level – from the University of Chicago, followed by his medical degree from the Pritzker School of Medicine at the University of Chicago. He completed a residency in radiation oncology at UCSF. Raleigh is a member of the American Society of Clinical Oncology, American Society for Radiation Oncology, Pacific Pediatric Neuro-Oncology Consortium, Children's Oncology Group, Society for Neuro-Oncology, International Meningioma Society and North American Skull Base Society. At the UCSF Brain Tumor Center, Raleigh is a principal investigator with the Wolfe Meningioma Program Project. Dr. Raleigh is rated as a Distinguished provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Meningioma, Pineocytoma, Brain Tumor, and Gliomatosis Cerebri.

Dr. Mitchel S. Berger is a nationally recognized expert in treating brain and spinal cord tumors as well as tumor-related epilepsy in adults and children. He also is a specialist in brain mapping techniques – used to identify and preserve areas of motor, sensory and language function during surgery – and an expert in using the Gamma Knife, a precise, noninvasive tool that applies radiation beams for tumor treatment. He is director of the Brain Tumor Center, director of the Center for Neurological Injury and Repair and co-director of the Adult Brain Tumor Surgery Program. Berger earned his bachelor's degree from Harvard College in 1975 and his medical degree from the University of Miami Miller School of Medicine in 1979. He completed an internship and a residency at UCSF, and was awarded a clinical fellowship in neuro-oncology by the American Cancer Society and a research fellowship by the Brain Tumor Research Center. He completed further fellowship training in neuro-oncology at UCSF and in pediatric neurosurgery at the Hospital for Sick Children, an affiliate of the University of Toronto. Berger was elected to the American Association of Neurological Surgeons' board of directors and appointed to the American Board of Neurological Surgery. Dr. Berger is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Astrocytoma, Glioma, Glioblastoma, Awake Craniotomy, and Endovascular Embolization.

Dr. Steve Braunstein is a radiation oncologist who cares for both adult and pediatric patients. He specializes in treating brain and spinal tumors, sarcomas, lymphoma and pediatric cancers. He also provides palliative radiotherapy to reduce symptoms in patients with advanced cancer. His expertise encompasses a number of technologies that use radiation as therapy, with a special focus on intraoperative radiotherapy and radiosurgery – using targeted high-dose radiation to destroy tumors, either as an alternative to surgical procedures or in combination with them. Braunstein's primary areas of research include improving radiation planning and treatment through the use of both gene marker analysis and advanced imaging technologies. He also studies how to improve the coordination, timing and delivery of health care that involves a variety of disciplines, including symptom management and cancer specialties. After earning his medical degree as well as a doctorate in biomedical sciences at New York University School of Medicine, Braunstein completed a residency in radiation oncology at UCSF. Braunstein is program director of UCSF's residency program and has a special interest in educating residents and medical students. He received a UCSF Medical Center Exceptional Physician Award in 2013. Braunstein serves as an editor for the International Journal of Radiation Oncology, Biology and Physics. He belongs to the American Society for Radiation Oncology, American Society of Clinical Oncology, Children's Oncology Group, Radiological Society of North America, North American Skull Base Society, International Gamma Knife Research Foundation and International Stereotactic Radiosurgery Society. He is active on committees within the National Cancer Institute, Children's Oncology Group and NRG Oncology. Dr. Braunstein is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Meningioma, Brain Tumor, Posterior Fossa Tumor, Gamma Knife Radiosurgery, and Osteotomy.

Dr. Nalin Gupta, chief of pediatric neurological surgery at UCSF Benioff Children's Hospital, is an expert in the evaluation and surgical management of neurological disorders in children, including epilepsy, brain tumors, hydrocephalus, and cranial and spinal birth defects. Gupta's primary research focuses on the role of inflammation in brain tumor progression. He is a principal investigator of the Brain Tumor Research Center at UCSF. He also is involved in national clinical studies of brain tumors and the effectiveness of fetal surgery for spina bifida. Gupta earned his medical degree and completed residency training in neurological surgery at the University of Toronto. He completed fellowship training in pediatric neurosurgery at the Hospital for Sick Children. He also has a doctorate in biophysics from UCSF. He served as an attending neurosurgeon at the University of Chicago before coming to UCSF. Dr. Gupta is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Gliomatosis Cerebri, Glioma, Brain Tumor, Osteotomy, and Craniectomy.

Dr. Jennie Taylor specializes in caring for adults with primary brain tumors, or tumors that start in the brain. As a member of the UCSF Brain Tumor Research Center, she is involved in developing new treatment strategies, innovative imaging techniques and comprehensive tumor analyses, with the goal of improving outcomes for patients with brain tumors. Taylor's research interests include analyzing molecular and imaging markers of resistance to current standard treatments for brain tumors. She also focuses on improving quality of life for patients with primary brain tumors as well as for their caregivers. Taylor earned her medical degree from the University of Kentucky College of Medicine. She completed an internship in medicine and a residency in neurology at the University of Virginia. She completed a fellowship in neuro-oncology at Massachusetts General Hospital and the Dana-Farber Cancer Institute while earning a master's degree in public health from the Harvard T.H. Chan School of Public Health. Taylor is a member of the American Academy of Neurology, Society for Neuro-Oncology and American Society of Clinical Oncology. Dr. Taylor is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Glioma, Astrocytoma, Brain Tumor, and Glioblastoma.

Anthony Barkovich is a Radiologist in San Francisco, California. Dr. Barkovich is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Cerebellar Hypoplasia, Polymicrogyria, Cortical Dysplasia, and Meningioma.

Corey Raffel is a General Surgeon in San Francisco, California. Dr. Raffel is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Medulloblastoma, Gliomatosis Cerebri, Brain Tumor, and Glioma.

Siddhartha Mitra is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Mitra is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Medulloblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Teratoma of the Mediastinum, and Febrile Neutropenia.

Alyssa Reddy is a Pediatric Neurologist in San Francisco, California. Dr. Reddy is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Gliomatosis Cerebri, and Glioma.

Amit Sabnis is a Hematologist and an Oncologist in San Francisco, California. Dr. Sabnis is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, Medulloblastoma, Osteotomy, and Bone Marrow Transplant.

Anuradha Banerjee is a Hematologist and an Oncologist in San Francisco, California. Dr. Banerjee is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Glioma, Pineoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, and Pediatric Low-Grade Glioma (pLGG).

Dr. Shawn Hervey-Jumper is a neurosurgeon specializing in the treatment of patients with brain tumors, including low- and high-grade gliomas, meningiomas, brain metastases and neurocutaneous syndromes. Hervey-Jumper's research investigates how brain tumors violate important areas of the brain that affect how we move, speak and think. He also explores strategies to promote brain recovery and repair. In addition, he researches ways to map the human brain during surgery with the goal of limiting injury to key functional areas. Hervey-Jumper received his medical degree from the Ohio State University College of Medicine. He completed both a residency in neurosurgery and a fellowship in neuro-oncology at the University of Michigan. He then completed a clinical fellowship in neuro-oncology at UCSF. Hervey-Jumper is a member of the Society for Neuro-Oncology, American Association for Cancer Research, North American Skull Base Society, American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS). He is also a member of the joint section on tumors for the latter organizations. He is an associate professor in residence of neurological surgery at UCSF. Dr. Hervey is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Glioma, Brain Tumor, Astrocytoma, Awake Craniotomy, and Gamma Knife Radiosurgery.

Dr. James Rubenstein is a hematologist-oncologist, or a specialist in blood disorders. He has particular expertise in treating patients with neurologic complications from cancer, including patients with non-Hodgkin's lymphoma involving the brain (called central nervous system lymphoma). He also specializes in patients with cancer that has spread to the brain from other parts of the body. In his research, Rubenstein investigates immunologic tools to improve tumor response to chemotherapy and radiation treatment, and to minimize toxicity from treatment. He is also interested in developing tumor biomarkers to diagnose brain tumors. Rubenstein earned his medical degree at Weill Cornell Medicine and completed a residency in internal medicine at Stanford Medicine. He earned a doctorate in molecular and cellular neurosciences at the Rockefeller University. He completed a fellowship in hematology and oncology at UCSF, which included training in neuro-oncology. Rubenstein has won research awards from the Leukemia & Lymphoma Society and the National Cancer Institute. He is a member of the American Society of Hematology, American Society of Clinical Oncology and American Association for Cancer Research. Dr. Rubenstein is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Primary Lymphoma of the Brain, Non-Hodgkin Lymphoma, Gastric Lymphoma, Vitrectomy, and Bone Marrow Aspiration.

Nancy Bush is a Neurologist in San Francisco, California. Dr. Bush is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Gliosarcoma, Glioblastoma, Embryonal Tumor with Multilayered Rosettes, and Astrocytoma. Dr. Bush is currently accepting new patients.

Dr. Manish Aghi is a neurosurgeon specializing in brain tumors at UCSF Medical Center. He cares for adult patients with a wide range of conditions, including astrocytomas and anaplastic astrocytomas, oligodendrogliomas, glioblastomas, meningiomas and pituitary adenomas. As principal investigator at the UCSF Brain Tumor Research Center, his interests include glioblastoma angiogenesis, mechanisms of glioblastoma resistance to anti-angiogenic therapy and experimental glioblastoma therapies such as cancer-killing viruses. Aghi earned his medical degree and a doctoral degree in neurosciences from Harvard Medical School. He completed a residency in neurosurgery at Massachusetts General Hospital. He is a member of the Society for Neuro-Oncology, American Association of Neurological Surgeons, Congress of Neurological Surgeons and Pituitary Network Association. Among his honors are the Preuss and Mahaley awards from the American Association of Neurological Surgeons, and the Ronald L. Bittner Award, Synthes Skull Base Award and Integra Foundation Award from the Congress of Neurological Surgeons. Dr. Aghi is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Pituitary Tumor, Hypothalamic Tumor, Prolactinoma, Balloon Sinuplasty, and Awake Craniotomy.

Dr. Philip Theodosopoulos is director of the Skull Base Tumor Program and vice chair of neurological surgery at UCSF. Before joining UCSF, he served as director of skull base surgery at the University of Cincinnati for 10 years. Theodosopoulos cares primarily for patients with skull base lesions, particularly malignancies and acoustic neuromas – noncancerous tumors that grow on nerves near the ear. His expertise includes endoscopic treatment of pituitary adenomas and chordomas as well as minimally invasive approaches to the skull base. Theodosopoulos has been a pioneer in the development of new surgical approaches to the skull base. He served as co-principal investigator for the largest prospective multicenter trial of surgical treatment for acoustic neuromas, and he currently serves on the Acoustic Neuroma Association's medical advisory board. He also has extensive expertise in research on patient outcomes. As a resident at UCSF, he completed the full curriculum for outcomes research and clinical epidemiology, and he continues to be involved in outcomes research at both the local and national levels. Theodosopoulos earned his undergraduate degree at the Massachusetts Institute of Technology and completed medical school at Stanford University. He completed his neurosurgical training at UCSF, followed by a fellowship in cerebrovascular and skull base surgery at the Brigham and Women's Hospital, an affiliate of Harvard Medical School. Theodosopoulos has been on the faculty for more than 50 national and international surgical courses. He serves on the education committee for the Congress of Neurological Surgeons. He serves as residency program director for neurological surgery at UCSF. Dr. Theodosopoulos is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Schwannoma, Acoustic Neuroma, Meningioma, Endoscopic Transnasal Transsphenoidal Surgery, and Balloon Sinuplasty.

Dr. Shagun Arora is a hematologist-oncologist who specializes in caring for patients with malignant and classical (cancerous and noncancerous) blood disorders. She treats patients with diverse hematologic conditions in both categories. Her focus is monoclonal gammopathies, or conditions in which the blood contains abnormal proteins, including MGUS (monoclonal gammopathy of undetermined significance) and multiple myeloma, along with anemias. Arora's goal is to provide compassionate, supportive care that takes the whole person into consideration, while helping patients fight cancer. She considers it a privilege to be part of the lives of cancer patients and their families. In addition to patient care, she is passionate about medical education, working closely with training physicians who are pursuing fellowships in hematology and oncology. Arora is the medical director of the Infusion Center at UCSF's Parnassus campus. Arora completed her residency at Michigan State University, followed by a fellowship at MedStar Washington Hospital Center and MedStar Georgetown University Hospital, where she served as chief fellow. She is a member of several professional associations, including the American Society of Hematology, American Society of Clinical Oncology, Society of Hematologic Oncology and International Myeloma Society. In her free time, Arora enjoys international travel, yoga retreats and hiking to view the gorgeous vistas of San Francisco. Dr. Arora is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Catherine Smith is a hematologist-oncologist who cares for patients with acute leukemia and myeloproliferative neoplasms (blood cancers that occur when the body overproduces one of the blood cell types). She specializes in acute myeloid leukemia (also known as acute myelogenous leukemia or AML), a cancer of the blood and bone marrow that spreads rapidly. She has a particular interest in treating AML patients who have mutations in the FLT3 gene, which is involved in leukemia cell growth, division and survival and is a factor that may be useful in making a prognosis. Smith's research focuses on understanding why some patients do not respond to AML therapies and on developing new strategies to treat these patients. A San Francisco native, Smith earned her medical degree from Duke University and completed a residency in internal medicine at Brigham and Women's Hospital. She then completed a fellowship in hematology and oncology at UCSF. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Essential Thrombocythemia, Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Myelofibrosis, and Bone Marrow Aspiration.

Dr. Lawrence D. Kaplan, a hematologist-oncologist, directs UCSF's lymphoma program. He is an international leader in the treatment of lymphoma and HIV-associated lymphoma. In his research, Kaplan is particularly interested in developing new treatments for lymphoma and the HIV-related form of this cancer. Kaplan earned his medical degree at the David Geffen School of Medicine at UCLA. He completed a residency in medicine at Boston Medical Center and completed a fellowship in hematology and oncology at UCSF. He joined UCSF in 1985. Kaplan's professional activities include serving on the Lymphoma Working Group of the AIDS Malignancy Consortium, a clinical trials group supported by the National Cancer Institute (NCI). He formerly chaired the group's steering committee. He also serves on the lymphoma committee of Alliance for Clinical Trials in Oncology, a national research group sponsored by the NCI. Dr. Kaplan is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Jennifer Clarke is a Neurologist in San Francisco, California. Dr. Clarke is rated as an Experienced provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Gliomatosis Cerebri.